Literature DB >> 3597445

The immunization of children with combined diphtheria and tetanus vaccine in Sweden.

K Larsen, K Ullberg-Olsson, B Wickbom, B Hederstedt.   

Abstract

Two groups derived from 97 children three-four months of age were vaccinated with diphtheria and tetanus vaccines containing either a routinely prepared diphtheria toxoid or a more purified preparation. Two injections were given with an interval of one month and a third injection was given one year after the first. Prior to the third injection no child was without protection against diphtheria, i.e. had an antitoxin titre less than 0.01 IU ml-1. After the third injection 95 and 94% of the children vaccinated with the routinely and more purified diphtheria toxoids, respectively, had diphtheria antitoxin titres greater than 1 IU ml-1 (estimated to provide protection for at least ten years). Systemic reactions such as fever and malaise occurred in five children. Local reactions greater than 10 cm were observed in three children and reactions greater than 5 but less than or equal to 10 cm were seen in 14% of the children. The routinely prepared combined diphtheria and tetanus vaccine, DT, produced very good immunity against diphtheria with moderate side effects. The use of a more purified diphtheria toxoid in the combined vaccine produced the same immunity and side effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597445     DOI: 10.1016/0092-1157(87)90033-3

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  2 in total

1.  Validation of the combined toxin-binding inhibition test for determination of neutralizing antibodies against tetanus and diphtheria toxins in a vaccine field study in Viet Nam.

Authors:  H A Hong; N T Ke; T N Nhon; N D Thinh; J W van der Gun; J T Hendriks; J G Kreeftenberg
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

2.  Immunity and immunization of children against diphtheria in Sweden.

Authors:  A Mark; B Christenson; M Granström; A Strandell; B Wickbom; M Böttiger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.